X

ILMN

Illumina, Inc (ILMN) TD Cowen 46th Annual Health Care Conference 2026

Illumina, Inc (NASDAQ: ILMN) FY 2026 Corporate Conference

Illumina, Inc (ILMN) Sec Form 10K

Illumina, Inc (NASDAQ: ILMN) Sec Form 10K

Illumina, Inc (ILMN) AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

Illumina, Inc (ILMN) Sec Form 8K

Illumina, Inc (NASDAQ: ILMN) Sec Form 8K

Illumina, Inc (ILMN) Q2 2025 Earnings Call Transcript

Illumina, Inc (NASDAQ: ILMN) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Brian Blanchett — Head of Investor…

Illumina, Inc (ILMN) Q3 2025 Earnings Call Transcript

Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Conor McNamara — Vice President, Investor…

Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export.…

Illumina Inc (ILMN) Q1 2023 Earnings Call Transcript

Illumina Inc (NASDAQ: ILMN) Q1 2023 earnings call dated Apr. 25, 2023 Corporate Participants: Salli Schwartz — Vice President of Investor Relations…

Illumina Inc (ILMN) Q4 2022 Earnings Call Transcript

Illumina Inc (NASDAQ:ILMN) Q4 2022 Earnings Call dated Feb. 07, 2023. Corporate Participants: Salli Schwartz — Vice-President of Investor Relations Francis deSouza — President…

Illumina, Inc (ILMN) Q3 2022 Earnings Call

Illumina, Inc (NASDAQ: ILMN) Q3 2022 Earnings Conference